Benzinga | Jan 25, 2021 08:07AM EST

BrainsWay Signs Exclusive Distribution Agreement With Gaelan Medical Trade LLC Under Which BrainsWay Will Supply Its Deep Transcranial Magnetic Stimulation System To Be Marketed And Sold Throughout UAE

CRESSKILL, N.J. and JERUSALEM, Jan. 25, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in the advanced non-invasive treatment of brain disorders, announced an exclusive distribution agreement with Gaelan Medical Trade LLC ("Gaelan"), a leading healthcare company with extensive distribution channels in the United Arab Emirates (UAE). The agreement establishes a multiyear framework whereby BrainsWay will supply its patented, revolutionary Deep Transcranial Magnetic Stimulation (Deep TMS) system, which is currently marketed in various markets for brain disorders including major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), to now be marketed and sold throughout the UAE.